Related Experiment Videos
Functionally active complement proteins C6 and C7 detected in C6- and C7-deficient individuals.
Clinical and Experimental Immunology
|March 1, 1991
Summary
Individuals with complement deficiencies in C6 and C7 can still form the terminal complement complex (TCC). Low levels of these proteins may offer protection against certain infections.
Area of Science:
- Immunology
- Complement System Biology
Background:
- Complement proteins C6 and C7 are crucial components of the terminal complement pathway.
- Deficiencies in these proteins can impact immune function and susceptibility to infections.
Purpose of the Study:
- To develop sensitive ELISAs for detecting complement proteins C6 and C7.
- To investigate the presence and function of C6 and C7 in individuals with diagnosed deficiencies.
- To assess the formation of the terminal complement complex (TCC) in these individuals.
Main Methods:
- Development of two sensitive sandwich ELISAs using monoclonal antibodies against native C6 and C7.
- Quantitation of C6 and C7 in serum samples from deficient individuals.
- Assay of terminal complement complex (TCC) formation after complement activation.
Main Results:
- Detection of C6 and/or C7 in 20 out of 37 serum samples from individuals classified as deficient.
- Serum from deficient individuals showed increased TCC and decreased C6/C7 after activation.
- Evidence of functionally active terminal complement proteins despite incomplete deficiencies.
Conclusions:
- Sensitive ELISAs can detect C6 and C7 in individuals with complement deficiencies.
- Individuals with C6/C7 deficiencies can still generate TCC, indicating residual protein function.
- Low concentrations of functional C6 and C7 may be sufficient for protection against neisserial infections.